SON is an essential m6A target for hematopoietic stem cell fate is a research paper published in Cell stem cell (2023). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
New York State Stem Cell Science
Grant: C32599GG
NIDDK
Grant: K99 DK128602-01
NIDDK
Grant: R01-DK101989-01A1
National Heart, Lung, and Blood Institute
Grant: R01 CA236911
National Heart, Lung, and Blood Institute
Grant: R01 HL168659
National Heart, Lung, and Blood Institute
Grant: R01HL157387-01A1
NHGRI
Grant: R01 HG013328-01A1
NCI
Grant: NCI P30 CA 008748
NCI
Grant: R01 CA274249-01A1
NCI
Grant: R01CA225231-01
NCI
Grant: R01HL135564
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: R01 CA186702
NIDDK NIH HHS
Grant: R01 DK101989
NCI NIH HHS
Grant: R01 CA225231
NIDDK NIH HHS
Grant: K99 DK128602
NCI NIH HHS
Grant: P50 CA254838
NHLBI NIH HHS
Grant: R01 HL157387
NCI NIH HHS
Grant: R01 CA274249
NCI NIH HHS
Grant: R01 CA283578
NCI NIH HHS
Grant: R01 CA193842
NHGRI NIH HHS
Grant: R01 HG013328
Leukemia and Lymphoma Society
Memorial Sloan-Kettering Cancer Center
AstraZeneca
National Institutes of Health
Howard Hughes Medical Institute
AbbVie
FWCI
1.68
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals